Completed OBSERVATIONAL NCT05138679

Evaluation of Acute Lower Limb Ischemia (PROMOTE-ALI)

Prospective Multicenter Observational Study Evaluating Acute Lower Limb Ischemia

Sponsor: Medical University Innsbruck

Interventions Best medical treatment Primary major amputation Revascularization

Updated 7 times since 2022 Last updated: Oct 30, 2023 Started: Dec 1, 2021 Primary completion: May 31, 2023 Completion: Aug 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Limb Ischemia and is currently completed. Medical University Innsbruck leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2023 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Sep 2023 — Nov 2023 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Mar 2022 — Sep 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jan 2022 — Mar 2022 [monthly]

Not Yet Recruiting

First recorded

Dec 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University Innsbruck

Data source: Medical University Innsbruck

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aachen, Germany , Amsterdam, Netherlands , Antibes, France , Belgrade, Serbia , Bern, Switzerland , Bordeaux, France , Boulogne-Billancourt, France , Brest, France , Bristol, United Kingdom , Budapest, Hungary and 22 more locations